COCH (Envoy Medical, Inc.) Stock Market Reviews

crown

search

Read and share opinions on COCH (Envoy Medical, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

COCH

Envoy Medical, Inc.

clarify Medical Devices

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Envoy Medical, Inc. (COCH) Reports Q3 Loss, Misses Revenue Estimates
Nov 10, 2025
Envoy Medical Reports Third Quarter 2025 Financial and Operational Results
Nov 10, 2025
Envoy Medical, Inc. (COCH) Expected to Beat Earnings Estimates: Should You Buy?
Nov 6, 2025
Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial
Nov 4, 2025
Envoy Medical Marks Three-Year Anniversary of First Patient Receiving Its Breakthrough Fully Implanted Cochlear Implant
Oct 29, 2025
Envoy Medical Receives Positive Listing Determination from NASDAQ
Oct 27, 2025
Envoy Medical to Present at the Virtual Technology Investor Conference on October 28th
Oct 23, 2025
Bears are Losing Control Over Envoy Medical, Inc. (COCH), Here's Why It's a 'Buy' Now
Oct 20, 2025
Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Oct 9, 2025
Envoy Medical Announces up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Oct 8, 2025
Envoy Medical Receives FDA Approval to Expand Its Pivotal Clinical Trial to Final Stage Based on Submission of Promising Three-Month Data
Oct 7, 2025
EXCLUSIVE: Envoy Medical Cuts Capital Needs After FDA Approval For Final Trial Stage Of Cochlear Implant Trial
Oct 7, 2025
Envoy Medical to Participate in the American Academy of Otolaryngology Head and Neck Surgery (AAO-HNSF) Conference on October 11th-14th
Oct 1, 2025
Envoy Medical Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Sep 25, 2025
Envoy Medical Advances Commercialization Planning for Breakthrough Hearing Device as FDA Clinical Trial Remains On Track
Sep 24, 2025

Reviews